{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:21:20Z","timestamp":1775870480946,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This work is supported by Shenzhen Second People\u2019s Hospital Clinical Research Fund of Shenzhen High-level Hospital Construction Project","award":["20223357071"],"award-info":[{"award-number":["20223357071"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-024-01497-w","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T12:52:54Z","timestamp":1731934374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The predictive value of nomogram for adnexal cystic-solid masses based on O-RADS US, clinical and laboratory indicators"],"prefix":"10.1186","volume":"24","author":[{"given":"Chunchun","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meifang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Bei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lvhuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"1497_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Cancer J Clin. 2023;73(1):17\u201348.","DOI":"10.3322\/caac.21763"},{"issue":"4","key":"1497_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0078-1","volume":"50","author":"SR Choe","year":"2018","unstructured":"Choe SR, Kim YN, Park CG, Cho KH, Cho DY, Lee HY. RCP induces FAK phosphorylation and ovarian cancer cell invasion with inhibition by curcumin. Exp Mol Med. 2018;50(4):1\u201310.","journal-title":"Exp Mol Med"},{"issue":"1","key":"1497_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s11427-023-2423-1","volume":"67","author":"S He","year":"2024","unstructured":"He S, Xia C, Li H, Cao M, Yang F, Yan X, et al. Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors. Sci China Life Sci. 2024;67(1):122\u201331.","journal-title":"Sci China Life Sci"},{"issue":"4","key":"1497_CR4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3322\/caac.21559","volume":"69","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. CA Cancer J Clin. 2019;69(4):280\u2013304.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1497_CR5","first-page":"598","volume":"19","author":"K Romanidis","year":"2014","unstructured":"Romanidis K, Nagorni EA, Halkia E, Pitiakoudis M. The role of cytoreductive surgery in advanced ovarian cancer: the general surgeon\u2019s perspective. J buon. 2014;19(3):598\u2013604.","journal-title":"J buon"},{"key":"1497_CR6","doi-asserted-by":"publisher","first-page":"978603","DOI":"10.3389\/fonc.2022.978603","volume":"12","author":"YC Wang","year":"2022","unstructured":"Wang YC, Tian JY, Han YY, Liu YF, Chen SY, Guo FJ. Evaluation of the potential of ultrasound-mediated drug delivery for the treatment of ovarian cancer through preclinical studies. Front Oncol. 2022;12:978603.","journal-title":"Front Oncol"},{"key":"1497_CR7","doi-asserted-by":"crossref","unstructured":"Avesani G, Panico C, Nougaret S, Woitek R, Gui B, Sala E. ESR essentials: characterisation and staging of adnexal masses with MRI and CT-practice recommendations by ESUR. Eur Radiol. 2024.","DOI":"10.1007\/s00330-024-10817-1"},{"issue":"1","key":"1497_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ygyno.2014.10.023","volume":"136","author":"WA Cliby","year":"2015","unstructured":"Cliby WA, Powell MA, Al-Hammadi N, Chen L, Philip Miller J, Roland PY, et al. Ovarian cancer in the United States: contemporary patterns of care associated with improved survival. Gynecol Oncol. 2015;136(1):11\u20137.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1497_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1148\/radiol.2019191150","volume":"294","author":"RF Andreotti","year":"2020","unstructured":"Andreotti RF, Timmerman D, Strachowski LM, Froyman W, Benacerraf BR, Bennett GL, et al. O-RADS US Risk Stratification and Management System: a Consensus Guideline from the ACR ovarian-adnexal reporting and Data System Committee. Radiology. 2020;294(1):168\u201385.","journal-title":"Radiology"},{"issue":"2","key":"1497_CR10","doi-asserted-by":"publisher","first-page":"e223269","DOI":"10.1148\/radiol.223269","volume":"308","author":"S Lee","year":"2023","unstructured":"Lee S, Lee JE, Hwang JA, Shin H, O-RADS US. A systematic review and Meta-analysis of category-specific Malignancy Rates. Radiology. 2023;308(2):e223269.","journal-title":"Radiology"},{"key":"1497_CR11","doi-asserted-by":"crossref","unstructured":"Phinyo P, Patumanond J, Saenrungmuaeng P, Chirdchim W, Pipanmekaporn T, Tantraworasin A et al. Diagnostic added-value of serum CA-125 on the IOTA simple rules and derivation of practical combined prediction models (IOTA SR X CA-125). Diagnostics (Basel). 2021;11(2).","DOI":"10.3390\/diagnostics11020173"},{"issue":"10","key":"1497_CR12","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.2174\/1389450121666200425211732","volume":"21","author":"K El Bairi","year":"2020","unstructured":"El Bairi K, Afqir S, Amrani M. Is HE4 Superior over CA-125 in the follow-up of patients with epithelial ovarian Cancer? Curr Drug Targets. 2020;21(10):1026\u201333.","journal-title":"Curr Drug Targets"},{"issue":"1","key":"1497_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13048-019-0503-7","volume":"12","author":"V Dochez","year":"2019","unstructured":"Dochez V, Caillon H, Vaucel E, Dimet J, Winer N, Ducarme G. Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review. J Ovarian Res. 2019;12(1):28.","journal-title":"J Ovarian Res"},{"key":"1497_CR14","doi-asserted-by":"publisher","first-page":"110926","DOI":"10.1016\/j.ejrad.2023.110926","volume":"165","author":"Y Yang","year":"2023","unstructured":"Yang Y, Ju H, Huang Y. Diagnostic performance of IOTA SR and O-RADS combined with CA125, HE4, and risk of malignancy algorithm to distinguish benign and malignant adnexal masses. Eur J Radiol. 2023;165:110926.","journal-title":"Eur J Radiol"},{"issue":"3","key":"1497_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ultrasmedbio.2020.11.007","volume":"47","author":"P Zhou","year":"2021","unstructured":"Zhou P, Jin C, Lu J, Xu L, Zhu X, Lian Q, et al. The value of Nomograms in Pre-operative Prediction of Lymphovascular Invasion in primary breast Cancer undergoing modified radical surgery: based on Multiparametric Ultrasound and Clinicopathologic indicators. Ultrasound Med Biol. 2021;47(3):517\u201326.","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"1497_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1148\/radiol.211868","volume":"304","author":"K Hack","year":"2022","unstructured":"Hack K, Gandhi N, Bouchard-Fortier G, Chawla TP, Ferguson SE, Li S, et al. External validation of O-RADS US Risk Stratification and Management System. Radiology. 2022;304(1):114\u201320.","journal-title":"Radiology"},{"issue":"1","key":"1497_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","volume":"112","author":"RG Moore","year":"2009","unstructured":"Moore RG, McMeekin DS, Brown AK, DiSilvestro P, Miller MC, Allard WJ, et al. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol. 2009;112(1):40\u20136.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"1497_CR18","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1046\/j.1469-0705.2000.00287.x","volume":"16","author":"D Timmerman","year":"2000","unstructured":"Timmerman D, Valentin L, Bourne TH, Collins WP, Verrelst H, Vergote I. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol. 2000;16(5):500\u20135.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"1497_CR19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00404-016-4035-8","volume":"293","author":"I Meinhold-Heerlein","year":"2016","unstructured":"Meinhold-Heerlein I, Fotopoulou C, Harter P, Kurzeder C, Mustea A, Wimberger P, et al. The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications. Arch Gynecol Obstet. 2016;293(4):695\u2013700.","journal-title":"Arch Gynecol Obstet"},{"issue":"30","key":"1497_CR20","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1002\/sim.3148","volume":"26","author":"W Sauerbrei","year":"2007","unstructured":"Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med. 2007;26(30):5512\u201328.","journal-title":"Stat Med"},{"issue":"1","key":"1497_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ygyno.2021.04.031","volume":"162","author":"L Cao","year":"2021","unstructured":"Cao L, Wei M, Liu Y, Fu J, Zhang H, Huang J, et al. Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): analysis on 1054 adnexal masses. Gynecol Oncol. 2021;162(1):107\u201312.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"1497_CR22","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/uog.24777","volume":"59","author":"AK Hiett","year":"2022","unstructured":"Hiett AK, Sonek JD, Guy M, Reid TJ. Performance of IOTA simple rules, simple rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in north American women. Ultrasound Obstet Gynecol. 2022;59(5):668\u201376.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1497_CR23","doi-asserted-by":"crossref","unstructured":"Timmerman S, Valentin L, Ceusters J, Testa AC, Landolfo C, Sladkevicius P, et al. Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups. JAMA Oncol. 2023;9(2):225\u201333. External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS).","DOI":"10.1001\/jamaoncol.2022.5969"},{"issue":"4","key":"1497_CR24","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/jum.16100","volume":"42","author":"R Yoeli-Bik","year":"2023","unstructured":"Yoeli-Bik R, Lengyel E, Mills KA, Abramowicz JS. Ovarian masses: the value of Acoustic shadowing on Ultrasound Examination. J Ultrasound Med. 2023;42(4):935\u201345.","journal-title":"J Ultrasound Med"},{"issue":"8","key":"1497_CR25","first-page":"815","volume":"80","author":"V Givens","year":"2009","unstructured":"Givens V, Mitchell GE, Harraway-Smith C, Reddy A, Maness DL. Diagnosis and management of adnexal masses. Am Fam Physician. 2009;80(8):815\u201320.","journal-title":"Am Fam Physician"},{"key":"1497_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.gore.2018.07.002","volume":"25","author":"NVQ Huy","year":"2018","unstructured":"Huy NVQ, Van Khoa V, Tam LM, Vinh TQ, Tung NS, Thanh CN, et al. Standard and optimal cut-off values of serum ca-125, HE4 and ROMA in preoperative prediction of ovarian cancer in Vietnam. Gynecol Oncol Rep. 2018;25:110\u20134.","journal-title":"Gynecol Oncol Rep"},{"issue":"1","key":"1497_CR27","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KG Moons","year":"2015","unstructured":"Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1\u201373.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1497_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000446238","volume":"82","author":"M Yanaranop","year":"2017","unstructured":"Yanaranop M, Anakrat V, Siricharoenthai S, Nakrangsee S, Thinkhamrop B. Is the risk of ovarian malignancy Algorithm Better Than other tests for Predicting Ovarian Malignancy in Women with Pelvic masses? Gynecol Obstet Invest. 2017;82(1):47\u201353.","journal-title":"Gynecol Obstet Invest"},{"issue":"2","key":"1497_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ygyno.2016.01.016","volume":"141","author":"C Romagnolo","year":"2016","unstructured":"Romagnolo C, Leon AE, Fabricio ASC, Taborelli M, Polesel J, Del Pup L, et al. HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: an Italian multicenter study. Gynecol Oncol. 2016;141(2):303\u201311.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1497_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3892\/ol.2013.1339","volume":"6","author":"Z Yang","year":"2013","unstructured":"Yang Z, Luo Z, Zhao B, Zhang W, Zhang J, Li Z, et al. Diagnosis and preoperative predictive value of serum HE4 concentrations for optimal debulking in epithelial ovarian cancer. Oncol Lett. 2013;6(1):28\u201334.","journal-title":"Oncol Lett"},{"issue":"1","key":"1497_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13048-023-01133-1","volume":"16","author":"LP Gong","year":"2023","unstructured":"Gong LP, Li XY, Wu YN, Dong S, Zhang S, Feng YN, et al. Nomogram based on the O-RADS for predicting the malignancy risk of adnexal masses with complex ultrasound morphology. J Ovarian Res. 2023;16(1):57.","journal-title":"J Ovarian Res"},{"key":"1497_CR32","doi-asserted-by":"publisher","first-page":"1284495","DOI":"10.3389\/fmed.2023.1284495","volume":"10","author":"Y Wu","year":"2023","unstructured":"Wu Y, Miao K, Wang T, Xu C, Yao J, Dong X. Prediction model of adnexal masses with complex ultrasound morphology. Front Med (Lausanne). 2023;10:1284495.","journal-title":"Front Med (Lausanne)"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01497-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-024-01497-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01497-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T13:03:33Z","timestamp":1731935013000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-024-01497-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1497"],"URL":"https:\/\/doi.org\/10.1186\/s12880-024-01497-w","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"31 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Ethics Committee of The First Affiliated Hospital of Shenzhen University (2024-097-01PJ). The requirement to obtain written informed patient consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors declared that they have no conflicts of interest in this work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"315"}}